08.26.15
The Supervisory Board of Symrise AG: appointed Olaf Klinger to become chief financial officer (CFO) of the company. He will join from private clinic operator AMEOS, where, as a managing executive, he is in charge of the finance department. Before that, he held various management positions during his many years at Merck KGaA.
On Feb. 1, 2016, he will take over the finance department at Symrise, thereby succeeding Bernd Hirsch. As announced in March 2015, Mr. Hirsch is leaving at his own request and on amicable terms at the end of the year.
Klinger has over 20 years of experience in corporate finance and also brings with him substantial expertise in the chemical and healthcare sectors. He was employed for over 12 years by the pharmaceutical and chemical company Merck in Darmstadt and acted as CFO for the Swiss subsidiary Merck Serono SA in Geneva. He held management positions in controlling, accounting, corporate finance, treasury and investor relations. Furthermore, he also led the introduction of the global financial organization of Merck, which he most recently headed. Profound experience in the fields of acquisition and integration of companies round out his professional profile.
In January 2015, Klinger transferred to the private clinic operator AMEOS Group where, as CFO, he was in charge of finance, IT and internal audit. He began his professional career in 1993 at Mannesmann where he worked in various management functions in Düsseldorf and New York.
On Feb. 1, 2016, he will take over the finance department at Symrise, thereby succeeding Bernd Hirsch. As announced in March 2015, Mr. Hirsch is leaving at his own request and on amicable terms at the end of the year.
Klinger has over 20 years of experience in corporate finance and also brings with him substantial expertise in the chemical and healthcare sectors. He was employed for over 12 years by the pharmaceutical and chemical company Merck in Darmstadt and acted as CFO for the Swiss subsidiary Merck Serono SA in Geneva. He held management positions in controlling, accounting, corporate finance, treasury and investor relations. Furthermore, he also led the introduction of the global financial organization of Merck, which he most recently headed. Profound experience in the fields of acquisition and integration of companies round out his professional profile.
In January 2015, Klinger transferred to the private clinic operator AMEOS Group where, as CFO, he was in charge of finance, IT and internal audit. He began his professional career in 1993 at Mannesmann where he worked in various management functions in Düsseldorf and New York.